1165017

Jeffrey G. Leflein, M.D. — FEI 3001452115

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 10, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Ypsilanti, MI (United States)

Additional Details

Clinical Investigator (CI)